Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000932 | P-body | 5 | 2 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 12 |
GO:0005829 | cytosol | 2 | 2 |
GO:0010494 | cytoplasmic stress granule | 5 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0035770 | ribonucleoprotein granule | 3 | 2 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0097165 | nuclear stress granule | 4 | 2 |
GO:0099080 | supramolecular complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: E9AFP0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003727 | single-stranded RNA binding | 5 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003730 | mRNA 3'-UTR binding | 6 | 2 |
GO:0005488 | binding | 1 | 12 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008143 | poly(A) binding | 7 | 2 |
GO:0008187 | poly-pyrimidine tract binding | 6 | 2 |
GO:0008266 | poly(U) RNA binding | 7 | 2 |
GO:0031369 | translation initiation factor binding | 3 | 2 |
GO:0031370 | eukaryotic initiation factor 4G binding | 4 | 2 |
GO:0070717 | poly-purine tract binding | 6 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.548 |
CLV_C14_Caspase3-7 | 575 | 579 | PF00656 | 0.551 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.541 |
CLV_NRD_NRD_1 | 366 | 368 | PF00675 | 0.509 |
CLV_NRD_NRD_1 | 371 | 373 | PF00675 | 0.509 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.498 |
CLV_PCSK_FUR_1 | 275 | 279 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 371 | 373 | PF00082 | 0.517 |
CLV_PCSK_KEX2_1 | 89 | 91 | PF00082 | 0.500 |
CLV_PCSK_PC1ET2_1 | 89 | 91 | PF00082 | 0.515 |
CLV_PCSK_PC7_1 | 273 | 279 | PF00082 | 0.535 |
CLV_PCSK_PC7_1 | 367 | 373 | PF00082 | 0.524 |
CLV_PCSK_PC7_1 | 85 | 91 | PF00082 | 0.511 |
CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 533 | 537 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.428 |
DOC_ANK_TNKS_1 | 119 | 126 | PF00023 | 0.473 |
DOC_MAPK_gen_1 | 117 | 126 | PF00069 | 0.462 |
DOC_MAPK_HePTP_8 | 307 | 319 | PF00069 | 0.487 |
DOC_MAPK_MEF2A_6 | 310 | 319 | PF00069 | 0.473 |
DOC_MAPK_MEF2A_6 | 554 | 562 | PF00069 | 0.462 |
DOC_PP1_RVXF_1 | 137 | 143 | PF00149 | 0.527 |
DOC_PP2B_PxIxI_1 | 7 | 13 | PF00149 | 0.321 |
DOC_PP4_FxxP_1 | 3 | 6 | PF00568 | 0.662 |
DOC_PP4_FxxP_1 | 354 | 357 | PF00568 | 0.540 |
DOC_PP4_FxxP_1 | 402 | 405 | PF00568 | 0.590 |
DOC_PP4_FxxP_1 | 415 | 418 | PF00568 | 0.582 |
DOC_PP4_FxxP_1 | 56 | 59 | PF00568 | 0.462 |
DOC_USP7_MATH_1 | 219 | 223 | PF00917 | 0.578 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 501 | 505 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.446 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.558 |
DOC_WW_Pin1_4 | 253 | 258 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 353 | 358 | PF00397 | 0.651 |
DOC_WW_Pin1_4 | 570 | 575 | PF00397 | 0.505 |
LIG_14-3-3_CanoR_1 | 120 | 126 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 139 | 143 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 539 | 544 | PF00244 | 0.558 |
LIG_14-3-3_CterR_2 | 590 | 594 | PF00244 | 0.624 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.570 |
LIG_BRCT_BRCA1_1 | 327 | 331 | PF00533 | 0.462 |
LIG_BRCT_BRCA1_1 | 378 | 382 | PF00533 | 0.679 |
LIG_Clathr_ClatBox_1 | 559 | 563 | PF01394 | 0.462 |
LIG_EVH1_2 | 398 | 402 | PF00568 | 0.699 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.473 |
LIG_FHA_1 | 312 | 318 | PF00498 | 0.467 |
LIG_FHA_1 | 361 | 367 | PF00498 | 0.455 |
LIG_FHA_1 | 554 | 560 | PF00498 | 0.471 |
LIG_FHA_2 | 573 | 579 | PF00498 | 0.500 |
LIG_GBD_Chelix_1 | 551 | 559 | PF00786 | 0.358 |
LIG_LIR_Apic_2 | 352 | 357 | PF02991 | 0.625 |
LIG_LIR_Gen_1 | 113 | 123 | PF02991 | 0.527 |
LIG_LIR_Gen_1 | 134 | 142 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 26 | 34 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 538 | 549 | PF02991 | 0.462 |
LIG_LIR_Gen_1 | 75 | 83 | PF02991 | 0.626 |
LIG_LIR_Nem_3 | 113 | 118 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 26 | 31 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 285 | 290 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 305 | 311 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 328 | 334 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 538 | 544 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 75 | 80 | PF02991 | 0.542 |
LIG_LYPXL_yS_3 | 287 | 290 | PF13949 | 0.417 |
LIG_REV1ctd_RIR_1 | 200 | 209 | PF16727 | 0.527 |
LIG_SH2_CRK | 137 | 141 | PF00017 | 0.502 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.474 |
LIG_SH2_CRK | 541 | 545 | PF00017 | 0.487 |
LIG_SH2_GRB2like | 53 | 56 | PF00017 | 0.462 |
LIG_SH2_NCK_1 | 137 | 141 | PF00017 | 0.473 |
LIG_SH2_STAP1 | 25 | 29 | PF00017 | 0.462 |
LIG_SH2_STAP1 | 541 | 545 | PF00017 | 0.558 |
LIG_SH2_STAT3 | 170 | 173 | PF00017 | 0.603 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 228 | 231 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.563 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 543 | 546 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.619 |
LIG_SH3_1 | 494 | 500 | PF00018 | 0.693 |
LIG_SH3_3 | 408 | 414 | PF00018 | 0.655 |
LIG_SH3_3 | 415 | 421 | PF00018 | 0.624 |
LIG_SH3_3 | 479 | 485 | PF00018 | 0.617 |
LIG_SH3_3 | 494 | 500 | PF00018 | 0.675 |
LIG_SH3_4 | 499 | 506 | PF00018 | 0.780 |
LIG_SUMO_SIM_anti_2 | 316 | 322 | PF11976 | 0.491 |
LIG_SUMO_SIM_par_1 | 256 | 261 | PF11976 | 0.550 |
LIG_SUMO_SIM_par_1 | 313 | 318 | PF11976 | 0.487 |
LIG_TRAF2_1 | 240 | 243 | PF00917 | 0.465 |
LIG_TRAF2_1 | 265 | 268 | PF00917 | 0.570 |
LIG_TRAF2_1 | 345 | 348 | PF00917 | 0.473 |
LIG_TYR_ITIM | 49 | 54 | PF00017 | 0.462 |
MOD_CDK_SPK_2 | 353 | 358 | PF00069 | 0.651 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.488 |
MOD_CK1_1 | 547 | 553 | PF00069 | 0.546 |
MOD_CK2_1 | 262 | 268 | PF00069 | 0.508 |
MOD_GlcNHglycan | 145 | 149 | PF01048 | 0.262 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.288 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.358 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.475 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.590 |
MOD_GSK3_1 | 311 | 318 | PF00069 | 0.502 |
MOD_GSK3_1 | 349 | 356 | PF00069 | 0.548 |
MOD_GSK3_1 | 486 | 493 | PF00069 | 0.773 |
MOD_GSK3_1 | 572 | 579 | PF00069 | 0.557 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.521 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.430 |
MOD_N-GLC_1 | 349 | 354 | PF02516 | 0.358 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.676 |
MOD_NEK2_1 | 258 | 263 | PF00069 | 0.444 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.469 |
MOD_NEK2_1 | 349 | 354 | PF00069 | 0.467 |
MOD_NEK2_1 | 360 | 365 | PF00069 | 0.409 |
MOD_NEK2_1 | 576 | 581 | PF00069 | 0.532 |
MOD_NEK2_2 | 33 | 38 | PF00069 | 0.462 |
MOD_NEK2_2 | 332 | 337 | PF00069 | 0.462 |
MOD_PIKK_1 | 340 | 346 | PF00454 | 0.546 |
MOD_PIKK_1 | 42 | 48 | PF00454 | 0.473 |
MOD_PIKK_1 | 486 | 492 | PF00454 | 0.764 |
MOD_PKA_1 | 89 | 95 | PF00069 | 0.489 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.475 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.473 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.473 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.467 |
MOD_Plk_1 | 258 | 264 | PF00069 | 0.563 |
MOD_Plk_1 | 295 | 301 | PF00069 | 0.473 |
MOD_Plk_2-3 | 572 | 578 | PF00069 | 0.556 |
MOD_Plk_4 | 315 | 321 | PF00069 | 0.490 |
MOD_Plk_4 | 350 | 356 | PF00069 | 0.487 |
MOD_Plk_4 | 501 | 507 | PF00069 | 0.709 |
MOD_Plk_4 | 539 | 545 | PF00069 | 0.546 |
MOD_Plk_4 | 572 | 578 | PF00069 | 0.556 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.420 |
MOD_ProDKin_1 | 253 | 259 | PF00069 | 0.463 |
MOD_ProDKin_1 | 353 | 359 | PF00069 | 0.651 |
MOD_ProDKin_1 | 570 | 576 | PF00069 | 0.505 |
MOD_SUMO_rev_2 | 16 | 24 | PF00179 | 0.456 |
MOD_SUMO_rev_2 | 191 | 199 | PF00179 | 0.487 |
MOD_SUMO_rev_2 | 572 | 582 | PF00179 | 0.462 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.527 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.462 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.474 |
TRG_ENDOCYTIC_2 | 541 | 544 | PF00928 | 0.462 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.654 |
TRG_ER_diArg_1 | 263 | 266 | PF00400 | 0.510 |
TRG_ER_diArg_1 | 275 | 278 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 382 | 385 | PF00400 | 0.578 |
TRG_ER_diArg_1 | 491 | 494 | PF00400 | 0.655 |
TRG_NES_CRM1_1 | 176 | 191 | PF08389 | 0.496 |
TRG_NLS_MonoExtN_4 | 87 | 93 | PF00514 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5A9 | Leptomonas seymouri | 90% | 100% |
A0A0S4IKZ4 | Bodo saltans | 57% | 100% |
A0A0S4JPT3 | Bodo saltans | 38% | 100% |
A0A1X0P4T3 | Trypanosomatidae | 37% | 100% |
A0A1X0P525 | Trypanosomatidae | 66% | 100% |
A0A3Q8IF40 | Leishmania donovani | 37% | 100% |
A0A3Q8IGR8 | Leishmania donovani | 36% | 100% |
A0A3Q8IMW2 | Leishmania donovani | 99% | 100% |
A0A3R7NAH9 | Trypanosoma rangeli | 36% | 100% |
A0A422NK82 | Trypanosoma rangeli | 66% | 100% |
A1CRM1 | Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) | 32% | 79% |
A1D4K4 | Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) | 33% | 79% |
A2Q848 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 33% | 81% |
A3LXL0 | Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) | 34% | 94% |
A4HDV5 | Leishmania braziliensis | 37% | 100% |
A4HN85 | Leishmania braziliensis | 91% | 100% |
A4HNG6 | Leishmania braziliensis | 37% | 100% |
A4I150 | Leishmania infantum | 36% | 100% |
A4IBV3 | Leishmania infantum | 99% | 100% |
A4IC57 | Leishmania infantum | 36% | 100% |
A4QUF0 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 35% | 78% |
A5DM21 | Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) | 34% | 94% |
A5DW14 | Lodderomyces elongisporus (strain ATCC 11503 / CBS 2605 / JCM 1781 / NBRC 1676 / NRRL YB-4239) | 36% | 90% |
C9ZYQ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
E9AFX7 | Leishmania major | 36% | 100% |
E9AX84 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
E9B6U3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
E9B730 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
F1QB54 | Danio rerio | 40% | 94% |
O22173 | Arabidopsis thaliana | 37% | 90% |
O64380 | Arabidopsis thaliana | 39% | 90% |
P04147 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 39% | 100% |
P0CP46 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 36% | 88% |
P0CP47 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 36% | 88% |
P11940 | Homo sapiens | 40% | 93% |
P20965 | Xenopus laevis | 40% | 94% |
P29341 | Mus musculus | 40% | 93% |
P31209 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 35% | 91% |
P42731 | Arabidopsis thaliana | 38% | 94% |
P61286 | Bos taurus | 40% | 93% |
Q05196 | Arabidopsis thaliana | 36% | 87% |
Q0CR95 | Aspergillus terreus (strain NIH 2624 / FGSC A1156) | 32% | 79% |
Q0U1G2 | Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) | 32% | 80% |
Q13310 | Homo sapiens | 40% | 92% |
Q1DXH0 | Coccidioides immitis (strain RS) | 34% | 77% |
Q1ZXC2 | Dictyostelium discoideum | 30% | 73% |
Q2GSX8 | Chaetomium globosum (strain ATCC 6205 / CBS 148.51 / DSM 1962 / NBRC 6347 / NRRL 1970) | 34% | 76% |
Q2UK72 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 33% | 78% |
Q4QA88 | Leishmania major | 36% | 100% |
Q4VXU2 | Homo sapiens | 38% | 97% |
Q4WK03 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 33% | 79% |
Q54BM2 | Dictyostelium discoideum | 32% | 100% |
Q5AI15 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 36% | 94% |
Q5B630 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 35% | 81% |
Q5R8F7 | Pongo abelii | 40% | 93% |
Q6BI95 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 34% | 95% |
Q6CDH3 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 32% | 94% |
Q6CSV3 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 33% | 100% |
Q6DEY7 | Xenopus tropicalis | 38% | 94% |
Q6FKG4 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 32% | 100% |
Q6GR16 | Xenopus laevis | 38% | 94% |
Q6IP09 | Xenopus laevis | 39% | 94% |
Q74ZS6 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 38% | 100% |
Q7S6N6 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 34% | 78% |
Q8SR30 | Encephalitozoon cuniculi (strain GB-M1) | 25% | 100% |
Q98SP8 | Xenopus laevis | 38% | 94% |
Q9EPH8 | Rattus norvegicus | 40% | 93% |
Q9FXA2 | Arabidopsis thaliana | 37% | 89% |
Q9ZQA8 | Arabidopsis thaliana | 31% | 98% |
V5BYR2 | Trypanosoma cruzi | 36% | 100% |
V5DUJ1 | Trypanosoma cruzi | 66% | 100% |